2015 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Mechanisms of Procedural Stroke in CEA and CAS Evaluated

September 2, 2015 -- In the European Journal of Vascular and Endovascular Surgery (EJVES), Anne Huibers, MD, et al published findings from an analysis of the features of …

MR CLEAN Substudy Shows Benefit of Larger Thrombi Retrieval During Intra-Arterial Treatment

September 1, 2015 -- The European Society of Cardiology (ESC) announced that findings from a substudy of the MR CLEAN trial demonstrated that retrieval of larger thrombi durin…

Funding Will Support Development of Centerline Biomedical’s GPS-Like Vascular Navigation System

August 31, 2015 -- Centerline Biomedical, Inc. announced that it recently closed on a $1.7-million seed investment to advance the development of its interventional vascul…

Surefire Precision Direct-to-Tumor Embolization Device Cleared by FDA

September 1, 2015 -- Surefire Medical, Inc. announced that the company has received US Food and Drug Administration 510(k) clearance for the Surefire Precision direct-to-tumor…

BTK Cohort Results Presented From QT Vascular’s Chocolate Registry

August 31, 2015 -- QT Vascular Ltd. announced that the final results of the below-the-knee (BTK) cohort of patients in the Chocolate Balloon Angioplasty Registry (BAR) were pr…

Greatbatch to Acquire Lake Region Medical

August 28, 2015 -- Greatbatch, Inc. announced that it has entered into a definitive agreement to acquire Lake Region Medical for approximately $1.73 billion in cash and stock.…

NIH Grant Will Support Symic Biomedical’s Development of Therapeutic Agent to Reduce Vascular Access Failures in End-Stage Renal Disease

August 26, 2015 -- Symic Biomedical, Inc. announced that it has received a $1.5 million phase 2 small-business innovation research grant from the National Institutes of H…

Click here for more News coverage

Current Supplements

Sponsored by BARD PERIPHERAL VASCULAR, INC.

The Evolution of SFA Care: The DCB Paradigm Shift

An in-depth look at how the science and clinical use of the first FDA-approved drug-coated balloon, LUTONIX® 035, continues to advance the treatment of PAD.

Sponsored by BOSTON SCIENTIFIC CORPORATION

The Emerging Role of Atherectomy in the Era of Drug-Elution

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $44.14  -0.23%
AstraZeneca PLC $32.24  1.77%
Boston Scientific Corporation $16.53  0.12%
BTG plc $644.50  1.98%
Cardiovascular Systems Inc. $22.98  -2.17%
CR Bard Inc. $190.39  -0.77%
Edwards Lifesciences Corp. $137.55  -1.06%
Endologix Inc. $12.74  1.27%
Hansen Medical, Inc. $0.53  1.33%
Vascular Market Price  Change
Johnson and Johnson $92.64  -0.76%
Lombard Medical, Inc. $3.95  -1.50%
Medtronic, Inc. $69.98  -2.19%
Merit Medical Systems, Inc. $22.79  1.15%
St. Jude Medical Inc. $70.38  -0.96%
The Medicines Company $40.12  -3.65%
The Spectranetics Corporation $16.39  -0.24%
TriVascular Technologies, Inc. $5.12  -3.03%
Vascular Solutions Inc. $33.69  -1.35%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media